Table: Takara Bio -Q1 group results
Jul 31 (Reuters)-
Takara Bio Inc.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Jun 30, 2018 Jun 30, 2017 Mar 31, 2019
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 8.85 6.36 36.80
(+39.2 pct) (+0.8 pct) (+13.9 pct)
Operating 1.54 262 mln 5.00
(+487.8 pct) (-59.2 pct) (+40.6 pct)
Recurring 1.56 287 mln 5.20
(+442.0 pct) (-56.0 pct) (+34.6 pct)
Net 1.03 22 mln 3.10
(-92.0 pct) (+32.8 pct)
EPS 8.57 yen 0.19 yen 25.74 yen
Ann Div 4.50 yen 6.00 yen
-Q2 div NIL NIL
-Q4 div 4.50 yen 6.00 yen
NOTE - Takara Bio Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T